A large body of evidence indicates that measurement of F2-isoprostanes, specific prostaglandin F2-like compounds derived from the non-enzymatic peroxidation of arachidonic acid, is a reliable biomarker of oxidant stress in the human body. Since the discovery of F2-isoprostanes in the early 1990s, a variety of analytical approaches has been introduced for the quantification of these novel compounds. The aim of the present review is to shed light on the available gas chromatographic–mass spectrometric assays for the measurement of plasma or urinary F2-isoprostanes and to highlight a number of issues which need to be addressed in order to implement F2-isoprostane measurement as a gold-standard biomarker of oxidative stress in biological samples.
Skip Nav Destination
Article navigation
October 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
September 19 2008
Key issues in F2-isoprostane analysis
Jaffar Nourooz-Zadeh
Jaffar Nourooz-Zadeh
1
1Department of Clinical and Nutritional Biochemistry, Urmia University of Medical Sciences, P.O. Box 1138, Urmia 57135, Iran
1email [email protected]
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
April 29 2008
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© The Authors Journal compilation © 2008 Biochemical Society
2008
Biochem Soc Trans (2008) 36 (5): 1060–1065.
Article history
Received:
April 29 2008
Citation
Jaffar Nourooz-Zadeh; Key issues in F2-isoprostane analysis. Biochem Soc Trans 1 October 2008; 36 (5): 1060–1065. doi: https://doi.org/10.1042/BST0361060
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Get Email Alerts
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |